Hypoxia Inducible Factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 7, 2011, Pages 909-918

  Huerta Yepez, S ^a   Baay Guzman, G J ^a   Bebenek, I G ^b   Hernandez Pando, R ^c   Vega, M I ^d   Chi, L ^b   Riedl, M ^b   Diaz Sanchez, D ^e   Kleerup, E ^b   Tashkin, D P ^b   Gonzalez, F J ^f   Bonavida, B ^g   Zeidler, M ^b,h   Hankinson, O ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Experimental Pathology Section   (Brazil)

^d HOSPITAL DE ONCOLOGÍA   (Mexico)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

allergic airway inflammation; asthma; hypoxia inducible factor; rhinitis

Indexed keywords

2 METHOXYESTRADIOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; OVALBUMIN; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; GENOTYPE; HUMAN; LUNG FLUID; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; RHINITIS; UPREGULATION; WILD TYPE;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ASTHMA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; RHINITIS; UP-REGULATION; YOUNG ADULT;

EID: 79958082195     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02594.x     Document Type: Article

References (34)

1. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al., Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836-844. (Pubitemid 39346477)
2. Weidemann A, Johnson RS,. Biology of HIF-1alpha. Cell Death Differ 2008; 15: 621-627.
3. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK,. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466-1471. (Pubitemid 34686328)
4. Vincent KA, Feron O, Kelly RA,. Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Trends Cardiovasc Med 2002; 12: 362-367. (Pubitemid 36092127)
5. Hu CJ, Sataur A, Wang L, Chen H, Simon MC,. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 2007; 18: 4528-4542. (Pubitemid 350060179)
6. Lau KW, Tian YM, Raval RR, Ratcliffe PJ, Pugh CW,. Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 2007; 96: 1284-1292. (Pubitemid 46625064)
7. Lee SY, Chung SM,. Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression. Vascul Pharmacol 2007; 47: 313-318. (Pubitemid 350008133)
8. Lee SY, Kwon S, Kim KH, Moon HS, Song JS, Park SH, et al., Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients. Ann Allergy Asthma Immunol 2006; 97: 794-799. (Pubitemid 46032432)
9. Huerta-Yepez S, Baay-Guzman GJ, Garcia-Zepeda R, Hernandez-Pando R, Vega MI, Gonzalez-Bonilla C, et al., 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immunol 2008; 129: 313-324.
10. Guo J, Lu W, Shimoda LA, Semenza GL, Georas SN,. Enhanced interferon-gamma gene expression in T Cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient mice. Int Arch Allergy Immunol 2009; 149: 98-102.
11. Fajardo I, Svensson L, Bucht A, Pejler G,. Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 2004; 170: 477-484. (Pubitemid 39209127)
12. Tomita S, Sinal CJ, Yim SH, Gonzalez FJ,. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol Endocrinol 2000; 14: 1674-1681.
13. Takagi S, Tojo H, Tomita S, Sano S, Itami S, Hara M, et al., Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J Clin Invest 2003; 112: 1372-1382. (Pubitemid 38057691)
14. Yepez SH, Pando RH, Argumedo LS, Paredes MV, Cueto AH, Isibasi A, et al., Therapeutic efficacy of an E coli strain carrying an ovalbumin allergenic peptide as a fused protein to OMPC in a murine model of allergic airway inflammation. Vaccine 2003; 21: 566-578. (Pubitemid 36091944)
15. Macy E, Kemeny M, Saxon A,. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB J 1988; 2: 3003-3009. (Pubitemid 18261419)
16. Aitola MH, Pelto-Huikko MT,. Expression of Arnt and Arnt2 mRNA in developing murine tissues. J Histochem Cytochem 2003; 51: 41-54. (Pubitemid 36138759)
17. Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, et al., cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol 1996; 16: 1706-1713.
18. Jain S, Maltepe E, Lu MM, Simon C, Bradfield CA,. Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 1998; 73: 117-123. (Pubitemid 28218548)
19. Kozak KR, Abbott B, Hankinson O,. ARNT-deficient mice and placental differentiation. Dev Biol 1997; 191: 297-305. (Pubitemid 28282914)
20. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC,. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403-407. (Pubitemid 27154481)
21. Majamaa K, Gunzler V, Hanauske-Abel HM, Myllyla R, Kivirikko KI,. Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J Biol Chem 1986; 261: 7819-7823. (Pubitemid 17208708)
22. Wang J, Buss JL, Chen G, Ponka P, Pantopoulos K,. The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells. FEBS Lett 2002; 529: 309-312.
23. Hagen T, D'Amico G, Quintero M, Palacios-Callender M, Hollis V, Lam F, et al., Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol. Biochem Biophys Res Commun 2004; 322: 923-929. (Pubitemid 39164441)
24. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al., 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3: 363-375. (Pubitemid 38340305)
25. Lee YC, Kwak YG, Song CH,. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 2002; 168: 3595-3600. (Pubitemid 34250430)
26. Lee KS, Kim SR, Park HS, Park SJ, Min KH, Lee KY, et al., A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp Mol Med 2007; 39: 756-768.
27. Reyes H, Reisz-Porszasz S, Hankinson O,. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992; 256: 1193-1195.
28. Probst MR, Fan CM, Tessier-Lavigne M, Hankinson O,. Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein. J Biol Chem 1997; 272: 4451-4457. (Pubitemid 27078523)
29. Ooe N, Saito K, Mikami N, Nakatuka I, Kaneko H,. Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression. Mol Cell Biol 2004; 24: 608-616. (Pubitemid 38057913)
30. Woods SL, Whitelaw ML,. Differential activities of murine single minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-Sim homology transcription factors. J Biol Chem 2002; 277: 10236-10243. (Pubitemid 34968138)
31. Lawrence BP, Denison MS, Novak H, Vorderstrasse BA, Harrer N, Neruda W, et al., Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008; 112: 1158-1165.
32. Saini Y, Kim KY, Lewandowski R, Bramble LA, Harkema JR, Lapres JJ,. Role of hypoxia-inducible factor 1{alpha} in modulating cobalt-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 2010; 298: L139-L147.
33. Semenza GL,. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-634.
34. Onnis B, Rapisarda A, Melillo G,. Development of HIF-1 inhibitors for cancer therapy. J Cell Mol Med 2009; 13: 2780-2786.